Activation of the transcription factor NFκB appears to be a prominent mechanism by which PAK1 potentially regulates survival of cancer cells40, 41; consistent with the hypothesis that combined MEK/mTOR inhibition in PTEN-loss contexts might synergistically inhibit tumor growth by selectively modulating a PAK/NFκB axis. The gene discussed is MTOR; the disease is neoplasm.